Public-registry site landscape for NCT07691762, a Hepatocellular Carcinoma study sponsored by Suzhou Suncadia Biopharmaceuticals Co., Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07691762 (registry record) |
| Sponsor | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
| Condition(s) | Hepatocellular Carcinoma |
| Phase | PHASE3 |
| Listed sites | 1 |
| Site countries | China |
At Zhongshan Hospital，Fudan University — one of the facilities listed on this trial — 27 other studies are actively recruiting Hepatocellular Carcinoma patients at the same facility (public registry, as of July 2026). Facility-level recruiting density is one of the strongest public correlates of enrollment pace in an indication.
Eichor generates a preliminary site-risk snapshot for NCT07691762 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →